Replies to post #13469 on PharmaRoth Labs, Inc. (ROTH)

[old biohf guy]

Mike, here is my understanding.

The FDA rejected an application by Roth to have sucanion sold over the counter, but the FDA rejected the application because sucanon appeared to them to be a drug and had to be approved as a drug. We all know that to be FDA approved as a drug costs lots of money and time which Roth did not have, so they did not submit an appliction. At that time the stock priced jump because stockholders viewed this as good that they were sitting on a drug vs a lesser product.

Mexico approved sucanon many years ago for over the counter sales.

Every country has its own rules to get approved for sale, some will be over the counter and some not.

Roth never sold any drugs in countries where they were not approved.

If I have any of this less than 100% correct or incomplete, then someone please comment.